Form 8-K - Current report:
SEC Accession No. 0001628280-24-002544
Filing Date
2024-01-30
Accepted
2024-01-30 16:12:54
Documents
14
Period of Report
2024-01-24
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 8-K jush-20240124.htm   iXBRL 8-K 28256
  Complete submission text file 0001628280-24-002544.txt   149664

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jush-20240124.xsd EX-101.SCH 1889
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jush-20240124_lab.xml EX-101.LAB 23081
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jush-20240124_pre.xml EX-101.PRE 12037
15 EXTRACTED XBRL INSTANCE DOCUMENT jush-20240124_htm.xml XML 2630
Mailing Address 301 YAMATO ROAD SUITE 3250 BOCA RATON FL 33431
Business Address 301 YAMATO ROAD SUITE 3250 BOCA RATON FL 33431 5616179100
Jushi Holdings Inc. (Filer) CIK: 0001909747 (see all company filings)

EIN.: 981547061 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56468 | Film No.: 24578271
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)